SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of 3D Systems — Neutral
DDD GlobeNewsWire — July 11, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In 3D Systems To Contact Him Directly To Discuss Their Options

Ford (NYSE: F) has made a name for itself as the recall leader of the car industry.

BP up 2% as fear over prospects recedes to acceptance — Positive
BP Proactive Investors — July 11, 2025BP PLC (LSE:BP.) shares rose 2% in afternoon trading after the energy group indicated that its second-quarter numbers and outlook were less bleak than many had feared, despite continued underperformance.

Kura Sushi: We Ate Well In The $50s, Now It's Time To Digest (Rating Downgrade) — Neutral
KRUS Seeking Alpha — July 11, 2025Kura Sushi delivered a strong Q3 double beat, with 17% revenue growth and a surprise profit, validating my earlier bullish call near $50 support. The company is executing well on its debt-free, high-growth model, expanding units over 20% year-over-year and managing costs despite macro headwinds. Same-store sales are still negative but improving sequentially, and new initiatives plus a robust IP calendar should drive further gains into FY 2026.

Is the Options Market Predicting a Spike in Flushing Financial Stock? — Neutral
FFIC Zacks Investment Research — July 11, 2025Investors need to pay close attention to FFIC stock based on the movements in the options market lately.

PepsiCo: What To Look For In Q2 Results And For The Long Run — Positive
PEP Seeking Alpha — July 11, 2025PepsiCo's near-term results are pressured by FX, tariffs, and capex, but underlying operations and international demand remain solid. Volume growth is the key catalyst for stabilizing the stock and supporting long-term FCF and dividend growth as capex normalizes. The current P/FCF multiple offers an attractive risk-reward opportunity for long-term investors. A return to growth could provide market-beating total returns.

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon — Neutral
OGN GlobeNewsWire — July 11, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options

TEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock? — Positive
TEVA Zacks Investment Research — July 11, 2025TEVA stock jumps 21.6% in three months on branded drug growth, biosimilar launches, and margin-boosting cost cuts.

Is the Options Market Predicting a Spike in Braze Stock? — Neutral
BRZE Zacks Investment Research — July 11, 2025Investors need to pay close attention to Braze stock based on the movements in the options market lately.

Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion — Neutral
IMMX GlobeNewsWire — July 11, 2025– Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis – – Potential future indication expansion planned – LOS ANGELES, July 11, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced a class-leading safety profile for sterically-optimized CAR-T NXC-201, including absence of neurotoxicity of any grade in low-volume disease to-date, laying a foundation for potential future indication expansion. “We …

Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential — Positive
AVGO MarketBeat — July 11, 2025AI semiconductor giant Broadcom NASDAQ: AVGO recently found its biggest bull on Wall Street yet. On June 24, analysts at HSBC issued a massive $400 price target on the stock.

A Sweet Spot Between Yield And Growth: The Best Balanced Dividend Growers For 2025 — Positive
ABBV CMCSA GPC PEP Seeking Alpha — July 11, 2025This isn't a buy list. It's a shortlist to help you speed up your research. We've included both U.S. and Canadian names, organized by country. Each company comes with a business summary, plus a bull and bear case to help you assess the fit. Comcast benefits from diversified cash flow through broadband, content creation, and international operations. The business remains cyclical—recessions hit industrial demand, and European expansion poses integration risks. Brand power and wide distribution provide resilience. PepsiCo is expanding its healthier product lines and boosting e-commerce. The shift toward healthier foods poses a threat to legacy products.

Gold market analysis for July 11 - key intra-day price entry levels for active traders — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — July 11, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Bitcoin Tops $118,000 in Another All-Time High — Positive
ARKB ARKW BETE BETH BITB BITC BITO BITQ BITS BITW BLKC BRRR BTCO BTCW BTF BTOP DEFI EZBC FBTC GBTC HODL IBIT SATO SPBC STCE WGMI XBTF Investopedia — July 11, 2025Bitcoin (BTCUSD) topped $118,000 for the first time, surpassing Thursday's record as it continued to gain from companies adding it to their corporate treasuries and lawmakers passing pro-crypto legislation.

JPMorgan Chase (JPM) reports earnings next week and will be among the "big bank" stocks to unofficially kickoff a new earnings season. Rick Ducat highlights key technical levels to watch on the 1-year chart before Tom White demonstrates an example options trade.

Best Income Stocks to Buy for July 11th — Positive
ISNPY TELNY VRTS Zacks Investment Research — July 11, 2025ISNPY, VRTS and TELNY made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 11, 2025.

Cousins Properties Stock Up 11% in Three Months: Will This Trend Last? — Positive
CUZ Zacks Investment Research — July 11, 2025CUZ stock jumps 11% on Sun Belt demand, trophy asset strategy and tenant return-to-office trends.

VIEWPOINT: How Thermal Energy Storage Can Maximize the Promise and Instill Safety in Nuclear SMRs — Neutral
BNRG Accesswire — July 11, 2025This third installment of Brenmiller Energy's (NASDAQ:BNRG) "Viewpoint" Series explores how the Company's bGen™ system can help unlock the full potential of Small Modular Reactor (SMR) technology. Energy industry veteran and Chief Executive Officer Avi Brenmiller explains how thermal energy storage can bridge the gap between safe, clean heat generation and real-world demand.

XPLR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – XIFR — Neutral
XIFR GlobeNewsWire — July 11, 2025SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP (NYSE: XIFR) securities between September 27, 2023 and January 27, 2025, both dates inclusive (the “Class Period”), have until September 8, 2025 to seek appointment as lead plaintiff of the XPLR class action lawsuit. Captioned Alvrus v.

Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants — Neutral
MIST GlobeNewsWire — July 11, 2025MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of (i) 31,500,000 of its common shares (the “Shares”), accompanying Series A common warrants (the “Series A Common Warrants”) to purchase an aggregate of 31,500,000 common shares and accompanying Series B common warrants (the “Series B Common Warrants”) to purchase an aggregate of 31,500,000 common shares , at a combined public offering price of $1.50 per share and …
